Jennifer Friel Goldstein

Managing Partner, Life Sciences and Healthcare, SVB Capital

Jennifer Friel Goldstein is the managing partner for Life Science and Healthcare Practice at SVB Capital and is a founding member of Venture Forward, a nonprofit that provides resources and education toward developing a diverse, equitable and inclusive venture capital (VC) ecosystem. She is also an advisory board member of Springboard Enterprises and the Women’s Health Innovation Coalition.

Jennifer has more than 20 years of experience in the VC and startup market segments, including leading and building several teams over the past eight years at Silicon Valley Bank. Before that, she was a director on Pfizer’s VC team, where she helped lead or co-lead investments into several life sciences companies. She also led fund of funds investment decisions and independently managed Pfizer’s $250 million private equity (PE) portfolio. Jennifer served as a consultant on PE deals across Europe while at Bain & Company and held operational and research roles at Chiron, Genelabs, and Genencor.

Jennifer graduated magna cum laude with a bachelor’s degree in bioengineering and a master’s degree in biotechnology from the University of Pennsylvania. She holds an MBA from the Wharton School, where she was named a Joseph Wharton Fellow. She also serves as an independent director at Alexandria Real Estate Equities, Inc. Jennifer lives in the Bay Area with her husband and their twin children.

Why is advancing the next era of venture capital important?

Venture capital is an American national treasure. It has fueled the advancement of innovation, economies, and people. It has created value, jobs, wealth, and life-changing products and services. Though venture capital as an industry may be young and as an asset class may be small, high-growth startups and their long-term investors have truly changed the world.

To continue the success of the industry’s past 50 years to the next 50 years and beyond, we must expand opportunities for people of all backgrounds to access the venture ecosystem and thrive. We must educate future leaders on best practices and help them learn from the industry’s rich history. We must help firms build strong, healthy cultures and values. We must keep the public and ecosystem informed through qualitative and quantitative insights.

By investing in tomorrow’s leaders today, we shape the next era of venture capital.

Learn More

10,000+

high-growth startups—across all 50 states and DC—raised venture funding in 2019 to build and grow their businesses.

42%

of all U.S. IPOs from 1974 to 2015 were venture-backed companies, representing 63% of the market capitalization and 85% of R&D.

2.9 million

is the average net jobs created annually between 1980 and 2010 by high-growth startups, which account for ~50% of gross jobs created in the U.S.

1,300+

U.S. venture firms are active today, managing an aggregate of $444 billion in assets.